LiverRisk评分在无肝病证据的退伍军人队列中预测长期肝脏相关结局
本研究为1999至2023年退伍军人健康管理系统的回顾性队列研究,纳入170998名无慢性肝病证据的退伍军人,按LiverRisk评分分为极低、低、中、高风险组。中位随访13.5年,9%发生肝脏相关事件,3.6%死于肝病,0.5%发生肝细胞癌。评分对肝脏相关事件、肝病死亡和肝细胞癌的C统计量分别为0.61、0.70和0.71,在西班牙裔/拉丁裔退伍军人中准确性最高。
要点
- LiverRisk评分可预测无肝病证据退伍军人的肝脏相关事件、肝病死亡和肝细胞癌。
- 评分在西班牙裔/拉丁裔退伍军人中预测肝病死亡和肝细胞癌的准确性高于非西班牙裔白人。
- 将评分整合至临床提醒和检验报告可能有助于主动患者管理和肝病预防。
核心结论
- LiverRisk评分能有效预测退伍军人中的肝脏相关事件、肝病死亡和肝细胞癌。
研究设计与样本
- 回顾性队列研究,纳入1999至2023年退伍军人健康管理局无慢性肝病、病毒性肝炎且LiverRisk评分完整的患者共170998人(93%男性,中位年龄60岁,63%白人)。
主要发现
- 中位随访13.5年,15463人(9%)发生肝脏相关事件,6219人(3.6%)死于肝病,640人(0.5%)发生肝细胞癌。
- LiverRisk评分预测肝脏相关事件的C统计量为0.61,肝病死亡为0.70,肝细胞癌为0.71。
- 西班牙裔/拉丁裔退伍军人中预测肝病死亡的C统计量为0.77(95%CI 0.73-0.81),肝细胞癌为0.82(95%CI 0.75-0.90);非西班牙裔白人肝病死亡为0.62(95%CI 0.61-0.62)。
关键数值与推荐
- LiverRisk评分风险分类:极低风险<6分,低风险6至<10分,中风险10至<15分,高风险≥15分。
- 队列中极低、低、中、高风险比例分别为71%、26%、2%和0.5%。
临床怎么用
- 可将LiverRisk评分整合至临床提醒和实验室报告中,以支持主动患者护理和肝病预防。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasing and disproportionately affects Hispanics. The LiverRisk score (LRS), a non-invasive stratification tool, could enhance early identification of patients at risk for liver disease; however, it has not been validated in a large U.S. Veteran cohort with sufficient liver-related outcomes. APPROACH: We conducted a retrospective cohort study of Veterans Health Administration (VHA) patients from 1999 to 2023. Individuals with chronic liver disease, viral hepatitis, or missing LRS values were excluded using laboratory and ICD-10 data. Patients were classified into minimal (LRS <6), low (6 to <10), medium (10 to <15), and high-risk (≥15) categories. Outcomes included liver-related events, mortality, hepatocellular carcinoma (HCC), and C-statistics. Analyses used parametric/non-parametric methods and Cox proportional hazard models with competing risks, adjusting for missing data. RESULTS: Among 170,998 Veterans (93% male; median age 60; 63% White), 71%, 26%, 2%, and 0.5% were classified as minimal-risk, low-risk, medium-risk, and high-risk, respectively. Over 13.5 years median follow-up, 15,463 (9%) developed a liver-related event, 6219 (3.6%) died of liver causes, and 640 (0.5%) developed HCC. C-statistics were 0.61 for events, 0.70 for mortality, and 0.71 for HCC. Accuracy was highest among Hispanic/Latino Veterans (mortality 0.77, 95% CI 0.73-0.81; HCC 0.82, 95% CI 0.75-0.90) versus non-Hispanic Whites (mortality 0.62, 95% CI 0.61-0.62). CONCLUSIONS: LRS effectively predicted liver-related events, mortality, and HCC in Veterans. Its integration into clinical alerts and lab reports could support proactive patient care and liver disease prevention.
引用
- Hernaez R, Liu Y, Serra-Burriel M, et al. LiverRisk score (LRS) predicts long-term liver-related outcomes in a cohort of Veterans without evidence of liver disease. Hepatology. 2026. PMID: 41525656. doi:10.1097/HEP.0000000000001669
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。